StockDriftsStockDriftsTop 2 Kck Ltd. Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| SGHT | Sight Sciences Inc | 99.66% | 4.37M | $15.0M | +0.00%(+0) | $21.35(-58.70%) | 2025-09-30 | |
| RNTX | Rein Theraputics Inc | 0.34% | 22.3K | $52K | +0.00%(+0) | $3.20(-61.29%) | 2025-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (8 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | +99.71% |
| Top 20 Holdings Unweighted | — | — | — | — | +56.07% |
Kck Ltd. reports $15.10M in US-listed equity holdings across 2 positions in its most recent 13F filing. Its largest disclosed positions are SGHT (99.7%) and RNTX (0.3%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned +99.71% cumulatively over 8 quarters. Figures reflect the Q3 2025 filing.
Sign up free to track Kck Ltd., compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Kck Ltd.’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1657662). View Kck Ltd.’s 13F filings on SEC